Celltrion’s infliximab biosimilar launches in Libya and Tunisia

Jun 25, 2018

Celltrion launches infliximab biosimilar in Libya and Tunisia. The product will be distributed through Celltrion’s local partner Hikma Pharmaceuticals and is part of Celltrion’s overall plan to expand sales networks across Africa and into the Middle East.

Print Page Mail Article